1. Home
  2. DVA vs EVR Comparison

DVA vs EVR Comparison

Compare DVA & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • EVR
  • Stock Information
  • Founded
  • DVA 1994
  • EVR 1995
  • Country
  • DVA United States
  • EVR United States
  • Employees
  • DVA N/A
  • EVR N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • EVR Investment Managers
  • Sector
  • DVA Health Care
  • EVR Finance
  • Exchange
  • DVA Nasdaq
  • EVR Nasdaq
  • Market Cap
  • DVA 10.5B
  • EVR 11.6B
  • IPO Year
  • DVA 1995
  • EVR 2006
  • Fundamental
  • Price
  • DVA $135.44
  • EVR $307.78
  • Analyst Decision
  • DVA Hold
  • EVR Buy
  • Analyst Count
  • DVA 2
  • EVR 8
  • Target Price
  • DVA $162.00
  • EVR $294.38
  • AVG Volume (30 Days)
  • DVA 925.7K
  • EVR 512.1K
  • Earning Date
  • DVA 08-05-2025
  • EVR 07-30-2025
  • Dividend Yield
  • DVA N/A
  • EVR 1.09%
  • EPS Growth
  • DVA 8.72
  • EVR 52.07
  • EPS
  • DVA 10.20
  • EVR 11.01
  • Revenue
  • DVA $13,161,328,000.00
  • EVR $3,238,871,000.00
  • Revenue This Year
  • DVA $6.51
  • EVR $10.19
  • Revenue Next Year
  • DVA $3.41
  • EVR $24.33
  • P/E Ratio
  • DVA $13.28
  • EVR $27.94
  • Revenue Growth
  • DVA 5.09
  • EVR 23.41
  • 52 Week Low
  • DVA $126.07
  • EVR $148.63
  • 52 Week High
  • DVA $179.60
  • EVR $324.06
  • Technical
  • Relative Strength Index (RSI)
  • DVA 46.24
  • EVR 60.29
  • Support Level
  • DVA $128.28
  • EVR $295.15
  • Resistance Level
  • DVA $135.58
  • EVR $315.25
  • Average True Range (ATR)
  • DVA 3.76
  • EVR 8.24
  • MACD
  • DVA -0.39
  • EVR -0.33
  • Stochastic Oscillator
  • DVA 44.11
  • EVR 65.00

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About EVR Evercore Inc.

Evercore Inc is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,380 employees at the end of 2024, and about 75% of its revenue is derived from the United States.

Share on Social Networks: